Moreover, assessing insulin effectiveness and intermediate hyperglycemia, like IGT, would require other diabetes-related parameters, such as OGTT to 2hPG or HbA1c (not considered by the WHO/IDF criteria) [10,11]. This evidence concerns the gene INS and diabetes mellitus.